Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuti Chernajovsky

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Molecular Medicine (Cambridge, Mass.)|July 4, 2013
Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptorIlaria Cervellini, Alexander Annenkov, Thomas Brenton, et al.
Biochimica Et Biophysica Acta|May 24, 2011
A chimeric receptor of the insulin-like growth factor receptor type 1 (IGFR1) and a single chain antibody specific to myelin oligodendrocyte glycoprotein activates the IGF1R signalling cascade in CG4 oligodendrocyte progenitorsAlexander Annenkov, Anne Rigby, Sandra Amor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
IL-12 and IL-10 expression synergize to induce the immune-mediated eradication of established colon and mammary tumors and lung metastasisM Verónica Lopez, Soraya K Adris, Alicia I Bravo, et al.
Annals of the Rheumatic Diseases|October 15, 2011
Molecular engineering of short half-life small peptides (VIP, αMSH and γ₃MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeuticsSandrine Vessillier, Gill Adams, Trinidad Montero-Melendez, et al.
Journal of Tissue Engineering and Regenerative Medicine|January 27, 2010
Quantitative imaging of cartilage and bone for functional assessment of gene therapy approaches in experimental arthritisKathryn S Stok, Danièle Noël, Florence Apparailly, et al.
Arthritis and Rheumatism|December 6, 2005
Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed jointAhuva Nissim, Paul G Winyard, Valerie Corrigall, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2004
T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alphaJoanna M Clark, Alexander E Annenkov, Manvinder Panesar, et al.
Arthritis Research & Therapy|July 1, 2005
The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammationJulia J Inglis, Ahuva Nissim, Delphine M Lees, et al.
Journal of Neuroimmunology|September 2, 2014
Growth associated protein (GAP-43): cloning and the development of a sensitive ELISA for neurological disordersSharmilee Gnanapavan, Nasim Yousaf, Wendy Heywood, et al.
Current Gene Therapy|December 30, 2014
Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscleMaria C Subang, Rewas Fatah, Ying Wu, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Molecular Medicine (Cambridge, Mass.)|July 4, 2013
Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptorIlaria Cervellini, Alexander Annenkov, Thomas Brenton, et al.
Biochimica Et Biophysica Acta|May 24, 2011
A chimeric receptor of the insulin-like growth factor receptor type 1 (IGFR1) and a single chain antibody specific to myelin oligodendrocyte glycoprotein activates the IGF1R signalling cascade in CG4 oligodendrocyte progenitorsAlexander Annenkov, Anne Rigby, Sandra Amor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
IL-12 and IL-10 expression synergize to induce the immune-mediated eradication of established colon and mammary tumors and lung metastasisM Verónica Lopez, Soraya K Adris, Alicia I Bravo, et al.
Annals of the Rheumatic Diseases|October 15, 2011
Molecular engineering of short half-life small peptides (VIP, αMSH and γ₃MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeuticsSandrine Vessillier, Gill Adams, Trinidad Montero-Melendez, et al.
Journal of Tissue Engineering and Regenerative Medicine|January 27, 2010
Quantitative imaging of cartilage and bone for functional assessment of gene therapy approaches in experimental arthritisKathryn S Stok, Danièle Noël, Florence Apparailly, et al.
Arthritis and Rheumatism|December 6, 2005
Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed jointAhuva Nissim, Paul G Winyard, Valerie Corrigall, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2004
T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alphaJoanna M Clark, Alexander E Annenkov, Manvinder Panesar, et al.
Arthritis Research & Therapy|July 1, 2005
The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammationJulia J Inglis, Ahuva Nissim, Delphine M Lees, et al.
Journal of Neuroimmunology|September 2, 2014
Growth associated protein (GAP-43): cloning and the development of a sensitive ELISA for neurological disordersSharmilee Gnanapavan, Nasim Yousaf, Wendy Heywood, et al.
Current Gene Therapy|December 30, 2014
Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscleMaria C Subang, Rewas Fatah, Ying Wu, et al.
Pageof 5